HighTower Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
HighTower Advisors's BCAT Position: Q1 2026 in Review
HighTower Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 3.8% in Q1 2026, buying an estimated $9.12K and bringing the position to 16,919 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3354.
HighTower Advisors first reported a position in BCAT in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.02M in Q4 2022. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- HighTower Advisors held 16,919 shares of BlackRock Capital Allocation Term Trust worth $239K as of Q1 2026.
- HighTower Advisors bought 619 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $9.12K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3354 holding.
- HighTower Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2021 and has held it in 10 quarters since.
- HighTower Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.02M in Q4 2022.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.